85 related articles for article (PubMed ID: 8101966)
21. A single point mutation in the seventh hydrophobic domain of the alpha 2-adrenergic receptor changes antagonist binding specificity to that of a beta receptor.
Suryanarayana S; Daunt DA; Von Zastrow M; Kobilka BK
Trans Assoc Am Physicians; 1991; 104():62-8. PubMed ID: 1688262
[No Abstract] [Full Text] [Related]
22. [Adrenergic receptor and alpha 2 agonist--2: Structure-function relationship of adrenoceptors].
Mizobe T
Masui; 1997 Jun; 46(6):770-6. PubMed ID: 9223879
[TBL] [Abstract][Full Text] [Related]
23. Iodinated analogs of trimetoquinol as highly potent and selective beta 2-adrenoceptor ligands.
De Los Angeles JE; Nikulin VI; Shams G; Konkar AA; Mehta R; Feller DR; Miller DD
J Med Chem; 1996 Sep; 39(19):3701-11. PubMed ID: 8809159
[TBL] [Abstract][Full Text] [Related]
24. The extracellular disulfide loop motif of the inhibitory glycine receptor does not form the agonist binding site.
Vandenberg RJ; Rajendra S; French CR; Barry PH; Schofield PR
Mol Pharmacol; 1993 Jul; 44(1):198-203. PubMed ID: 8393521
[TBL] [Abstract][Full Text] [Related]
25. Mutagenesis analysis of the serotonin 5-HT2C receptor and a Caenorhabditis elegans 5-HT2 homologue: conserved residues of helix 4 and helix 7 contribute to agonist-dependent activation of 5-HT2 receptors.
Xie J; Dernovici S; Ribeiro P
J Neurochem; 2005 Jan; 92(2):375-87. PubMed ID: 15663485
[TBL] [Abstract][Full Text] [Related]
26. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
[TBL] [Abstract][Full Text] [Related]
27. [Interaction between receptors and biologically active substances in tumor cells].
Solntseva TI; Khabarov SV; Mikhaevich IS
Vestn Akad Med Nauk SSSR; 1986; (8):23-31. PubMed ID: 2876559
[No Abstract] [Full Text] [Related]
28. A point mutation in the seventh hydrophobic domain of the alpha 2 adrenergic receptor increases its affinity for a family of beta receptor antagonists.
Suryanarayana S; Daunt DA; Von Zastrow M; Kobilka BK
J Biol Chem; 1991 Aug; 266(23):15488-92. PubMed ID: 1678390
[TBL] [Abstract][Full Text] [Related]
29. Analysis of hydrophobic interactions of antagonists with the beta2-adrenergic receptor.
Novoseletsky VN; Pyrkov TV; Efremov RG
SAR QSAR Environ Res; 2010 Jan; 21(1):37-55. PubMed ID: 20373213
[TBL] [Abstract][Full Text] [Related]
30. Identification of residues required for ligand binding to the beta-adrenergic receptor.
Strader CD; Sigal IS; Register RB; Candelore MR; Rands E; Dixon RA
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4384-8. PubMed ID: 2885836
[TBL] [Abstract][Full Text] [Related]
31. Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function.
Strader CD; Sigal IS; Candelore MR; Rands E; Hill WS; Dixon RA
J Biol Chem; 1988 Jul; 263(21):10267-71. PubMed ID: 2899076
[TBL] [Abstract][Full Text] [Related]
32. Structure-function of alpha1-adrenergic receptors.
Perez DM
Biochem Pharmacol; 2007 Apr; 73(8):1051-62. PubMed ID: 17052695
[TBL] [Abstract][Full Text] [Related]
33. Molecular modeling of a putative antagonist binding site on helix III of the beta-adrenoceptor.
van Vlijmen HW; IJzerman AP
J Comput Aided Mol Des; 1989 Jun; 3(2):165-74. PubMed ID: 2570825
[TBL] [Abstract][Full Text] [Related]
34. Identification of intramolecular interactions in adrenergic receptors.
Suryanarayana S; von Zastrow M; Kobilka BK
J Biol Chem; 1992 Nov; 267(31):21991-4. PubMed ID: 1331041
[TBL] [Abstract][Full Text] [Related]
35. Selective binding of ligands to beta 1, beta 2 or chimeric beta 1/beta 2-adrenergic receptors involves multiple subsites.
Marullo S; Emorine LJ; Strosberg AD; Delavier-Klutchko C
EMBO J; 1990 May; 9(5):1471-6. PubMed ID: 1970295
[TBL] [Abstract][Full Text] [Related]
36. The forgotten serine. A critical role for Ser-2035.42 in ligand binding to and activation of the beta 2-adrenergic receptor.
Liapakis G; Ballesteros JA; Papachristou S; Chan WC; Chen X; Javitch JA
J Biol Chem; 2000 Dec; 275(48):37779-88. PubMed ID: 10964911
[TBL] [Abstract][Full Text] [Related]
37. Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor.
Dohlman HG; Caron MG; DeBlasi A; Frielle T; Lefkowitz RJ
Biochemistry; 1990 Mar; 29(9):2335-42. PubMed ID: 2159799
[TBL] [Abstract][Full Text] [Related]
38. [Membrane receptors and drug effects].
Pöch G
Med Klin; 1980 Oct; 75(22):778-83. PubMed ID: 6109230
[No Abstract] [Full Text] [Related]
39. [Does the self-stimulating effect of beta receptor blockaders play any role in the choice of drug and treatment results?].
Erikssen J; Thaulow E; Amlie J
Tidsskr Nor Laegeforen; 1983 May; 103(13):1083-6. PubMed ID: 6136103
[No Abstract] [Full Text] [Related]
40. Mutagenesis of the beta 2-adrenergic receptor: how structure elucidates function.
Ostrowski J; Kjelsberg MA; Caron MG; Lefkowitz RJ
Annu Rev Pharmacol Toxicol; 1992; 32():167-83. PubMed ID: 1318669
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
